Murchinson Ltd. Sells 4,933 Shares of Amedisys, Inc. (NASDAQ:AMED)

Murchinson Ltd. reduced its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 6.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 68,330 shares of the health services provider’s stock after selling 4,933 shares during the quarter. Amedisys accounts for 1.2% of Murchinson Ltd.’s portfolio, making the stock its 12th biggest holding. Murchinson Ltd.’s holdings in Amedisys were worth $6,273,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Treasurer of the State of North Carolina grew its position in Amedisys by 1.0% in the 4th quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock worth $1,350,000 after purchasing an additional 140 shares during the period. Arizona State Retirement System boosted its stake in shares of Amedisys by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after buying an additional 177 shares during the last quarter. Bridge City Capital LLC grew its holdings in shares of Amedisys by 0.8% in the first quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock worth $2,752,000 after acquiring an additional 231 shares during the period. Price T Rowe Associates Inc. MD increased its position in Amedisys by 0.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock valued at $2,876,000 after acquiring an additional 255 shares during the last quarter. Finally, Texas Permanent School Fund Corp lifted its holdings in Amedisys by 1.4% in the first quarter. Texas Permanent School Fund Corp now owns 28,560 shares of the health services provider’s stock valued at $2,632,000 after acquiring an additional 381 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AMED has been the subject of a number of recent research reports. Cantor Fitzgerald restated a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research note on Thursday, July 25th. William Blair lowered shares of Amedisys from an “outperform” rating to a “market perform” rating in a research report on Monday, July 1st. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research report on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $100.67.

Amedisys Stock Down 0.4 %

AMED stock opened at $96.87 on Tuesday. The business’s 50-day moving average price is $97.67 and its 200-day moving average price is $94.87. The stock has a market cap of $3.17 billion, a P/E ratio of -151.36, a PEG ratio of 1.89 and a beta of 0.78. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Amedisys, Inc. has a twelve month low of $89.55 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.10. The business had revenue of $591.19 million for the quarter, compared to the consensus estimate of $579.34 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. On average, equities research analysts forecast that Amedisys, Inc. will post 4.66 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.